menu
    • menu

    Company profile for CinCor Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CinCor is a clinical-stage biopharmaceutical company focused on developing our lead clinical candidate, baxdrostat, for the treatment of hypertension and other cardio-renal diseases. Baxdrostat is a highly selective, oral small molecule inhibitor of aldosterone synthase, the enzyme responsible for the synthesis of aldosterone in the adrenal gland. Baxdrostat has been designed to use a differentiated mechanism of action, direct...
    CinCor is a clinical-stage biopharmaceutical company focused on developing our lead clinical candidate, baxdrostat, for the treatment of hypertension and other cardio-renal diseases. Baxdrostat is a highly selective, oral small molecule inhibitor of aldosterone synthase, the enzyme responsible for the synthesis of aldosterone in the adrenal gland. Baxdrostat has been designed to use a differentiated mechanism of action, direct inhibition of aldosterone synthase production, with the goal of providing an improved treatment for patients suffering from hypertension, or high blood pressure.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CinCor PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    230 Third Avenue 6th Floor Waltham, MA 02451
    Telephone
    Telephone
    513-800-2585
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cincor.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cincor/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cincorpharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ex-CinCor CEO Marc de Garidel lands at Abivax after negotiating $1.8B cash sale
    Ex-CinCor CEO Marc de Garidel lands at Abivax after negotiating $1.8B cash sale

    06 Apr 2023

    // Amber Tong ENDPTS

    https://endpts.com/after-negotiating-1-8b-cash-sale-ex-cincor-ceo-marc-de-garidel-lands-at-abivax/

    Amber Tong ENDPTS
    06 Apr 2023
    Share Share
    AstraZeneca Acquires CinCor for $1.3B Upfront
    AstraZeneca Acquires CinCor for $1.3B Upfront

    03 Mar 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-03/astrazeneca-acquires-cincor-for-13b-upfront/?widget=listSection

    CONTRACT PHARMA
    03 Mar 2023
    Share Share
    CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat
    CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat

    21 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/21/2612072/0/en/CinCor-Pharma-Announces-Receipt-of-Minutes-from-End-of-Phase-2-Meeting-with-the-U-S-Food-and-Drug-Administration-on-Planned-Phase-3-Program-of-Baxdrostat.html

    GLOBENEWSWIRE
    21 Feb 2023
    Share Share
    AstraZeneca eagerness for CinCor revealed in larger first offer
    AstraZeneca eagerness for CinCor revealed in larger first offer

    24 Jan 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/behind-deal-astrazenecas-eagerness-cincor-acquisition-revealed-larger-initial-offer

    James Waldron FIERCE BIOTECH
    24 Jan 2023
    Share Share
    How the price of AstraZeneca's buyout of Cincor fell by $1.4B
    How the price of AstraZeneca's buyout of Cincor fell by $1.4B

    23 Jan 2023

    // Nicole DeFeudis ENDPTS

    https://endpts.com/how-the-price-of-astrazenecas-buyout-of-cincor-fell-by-1-4b/

    Nicole DeFeudis ENDPTS
    23 Jan 2023
    Share Share
    AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
    AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

    23 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230122005024/en

    BUSINESSWIRE
    23 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search